<?xml version="1.0" encoding="UTF-8"?>
<ref id="B101-nutrients-12-03782">
 <label>101.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Budoff</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Brent Muhlestein</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Le</surname>
    <given-names>V.T.</given-names>
   </name>
   <name>
    <surname>May</surname>
    <given-names>H.T.</given-names>
   </name>
   <name>
    <surname>Roy</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Nelson</surname>
    <given-names>J.R.</given-names>
   </name>
  </person-group>
  <article-title>Effect of Vascepa (icosapent ethyl) on progression of coronary atherosclerosis in patients with elevated triglycerides (200â€“499 mg/dL) on statin therapy: Rationale and design of the EVAPORATE study</article-title>
  <source>Clin. Cardiol.</source>
  <year>2018</year>
  <volume>41</volume>
  <fpage>13</fpage>
  <lpage>19</lpage>
  <pub-id pub-id-type="doi">10.1002/clc.22856</pub-id>
  <pub-id pub-id-type="pmid">29365351</pub-id>
 </element-citation>
</ref>
